Skip to main content
. 2017 Aug 2;8(50):87292–87306. doi: 10.18632/oncotarget.19823

Figure 5. Kaplan–Meier survival curves analysis of the six LUAD-SDGs for overall survival of LUAD patients.

Figure 5

(A-F) The expression of six LUAD-SDGs including RP11-513N24.1, CHIAP2, RP11-206P5.2, BMP5, SFTPB and MS4A15 was positively associated with overall survival of LUAD patients (P < 0.001).